Left Ventricular Systolic Function: Comprehensive Assessment

Left ventricular systolic function is central to diagnosing and managing heart failure, ischemic heart disease, cardiomyopathies, and valvular disease. Ejection fraction gets most of the attention, but it’s really just one parameter in a broader toolkit — this tutorial covers the M-mode, 2D, Doppler, and strain-based parameters that, together, give a genuinely comprehensive picture of both global and regional systolic function. See the Left Ventricular Ejection Fraction tutorial for a focused, detailed treatment of EF measurement specifically.

M-Mode Parameters

M-mode remains useful for assessing wall contractility directly — wall thickness, systolic wall thickening, and the uniformity of wall motion — and for several specific diagnostic signs:

• A “B bump” (or “A-C shoulder”) on the mitral valve M-mode trace — a flattening of the normally linear A-to-C closure slope — appears when LV end-diastolic pressure is elevated. The same kind of finding on the tricuspid valve reflects elevated right ventricular end-diastolic pressure.
• Mitral E-point septal separation (EPSS) — the distance between the anterior mitral leaflet’s peak early-diastolic excursion and the septum — increases with LV dilation or reduced systolic function (in the absence of mitral stenosis, which would confound it). A markedly increased EPSS is commonly cited as suggesting significantly reduced EF, though the exact correlation is a general association rather than a precise measurement — don’t use EPSS alone in place of a proper EF calculation.
• Premature mitral valve closure (the M-mode “C point” occurring at or before the QRS) and premature aortic valve opening both reflect a rapidly rising LV diastolic pressure — classically discussed in the context of acute severe aortic regurgitation; see the Aortic Regurgitation tutorial for more on this.
• LVIDd and LVIDs (LV internal dimension at end-diastole and end-systole) allow calculation of fractional shortening (FS) and, via the Teichholz method, an M-mode-derived estimate of EF. Both assume a predictable ellipsoid LV geometry and a uniformly contracting ventricle — assumptions that break down with regional wall motion abnormalities or a distorted LV shape, which is why the Teichholz method is a quick estimate, not a substitute for a proper 2D volumetric measurement when accuracy matters.

Normal Values (Current Guideline-Based Ranges)

The table below reflects the current ASE/EACVI chamber quantification standards, with normal ranges and severity partitions by sex. Note that these are narrower than some older reference tables — a normal EF range of “48–78%,” for instance, is sometimes still seen in older teaching materials, but the current standard is meaningfully narrower:

Parameter	Male: Normal	Mild	Moderate	Severe
LV ejection fraction	52–72%	41–51%	30–40%	< 30%
Fractional shortening	28–44%	—	—	—
LV diastolic diameter	4.2–5.8 cm	5.9–6.3 cm	6.4–6.8 cm	> 6.8 cm
LV systolic diameter	2.5–4.0 cm	4.1–4.3 cm	4.4–4.5 cm	> 4.5 cm

Parameter	Female: Normal	Mild	Moderate	Severe
LV ejection fraction	54–74%	41–53%	30–40%	< 30%
Fractional shortening	28–44%	—	—	—
LV diastolic diameter	3.8–5.2 cm	5.3–5.6 cm	5.7–6.1 cm	> 6.1 cm
LV systolic diameter	2.2–3.5 cm	3.6–3.8 cm	3.9–4.1 cm	> 4.1 cm

Other commonly referenced M-mode and Doppler-derived indices, useful as quick bedside checks though less frequently reported in a formal study than the parameters above:

• PEP/LVET (pre-ejection period to LV ejection time ratio) — typically well under 0.42; rises with impaired systolic function
• Mean velocity of circumferential fiber shortening (Vcf) — roughly 1.0–1.9 circ/s in a normal ventricle
• Stroke volume and cardiac output — roughly 75–100 mL and 4–8 L/min at rest, though both scale with body size, which is why cardiac index (cardiac output divided by body surface area, roughly 2.4–4.2 L/min/m²) is the more comparable figure across different-sized patients

A note on sourcing: PEP/LVET, Vcf, and the absolute stroke volume/cardiac output/cardiac index ranges above are standard, long-established teaching values, but weren’t independently re-verified against the specific current guideline documents reviewed for this page — treat them as generally reliable reference points rather than guideline-sourced cutoffs.

2D Echocardiography

Global Function

2D imaging provides both a qualitative overall impression of LV contractility and the basis for quantitative EF calculation (Simpson’s biplane method of discs, or the area-length method) — see the dedicated Ejection Fraction tutorial for the full detail on these quantitative methods and where they can go wrong.

Mitral annular plane systolic excursion (“descent of the base”) — the longitudinal displacement of the mitral annulus toward the apex during systole — is a simple, complementary marker of longitudinal LV function: reasonable excursion is generally associated with preserved LV function, and a reduced excursion can be an early clue to systolic dysfunction even before a formal EF calculation is complete.

Regional Wall Motion Assessment

Regional wall motion abnormalities (RWMA) are most often caused by ischemia or infarction, and assessing them by territory — not just noting that “something is abnormal” — is what makes echo clinically useful for localizing disease. The LV is divided into a 16- or 17-segment model, mapped to the three major coronary territories (LAD, LCx, RCA), and each segment is scored:

Score	Wall motion	Description
1	Normal	Full, symmetric thickening and inward motion during systole
2	Hypokinetic	Reduced thickening and inward motion
3	Akinetic	Absent thickening or motion
4	Dyskinetic	Paradoxical outward motion during systole

Averaging the scores across all segments gives a wall motion score index — a simple, reproducible summary number that correlates with overall LV function and prognosis, independent of a formal EF measurement. Regional assessment matters clinically in several distinct ways: localizing an infarct territory, monitoring for recovery of function after revascularization, and — during stress echocardiography — identifying new or worsening regional dysfunction that indicates inducible ischemia. See Stress Echocardiography for the full wall-motion-response framework this scoring feeds into.

A note on Fractional Area Change (FAC): FAC is sometimes listed as an LV parameter, but it is fundamentally a right ventricular measurement (RV FAC, normal roughly 32–60%, from the apical four-chamber view) — the RV equivalent of EF, used because the RV’s complex geometry doesn’t lend itself to the same volumetric methods as the LV. If you see “FAC” applied to the left ventricle, that’s worth double-checking against the source, since it’s not a standard LV quantification parameter in current guidelines.

Doppler Parameters

• Aortic outflow velocity and VTI — the shape and magnitude of the LVOT/aortic Doppler tracing give a quick qualitative read on outflow dynamics, and the velocity-time integral (VTI) — combined with LVOT diameter — is how stroke volume and cardiac output are actually calculated by Doppler (see the Transthoracic Echocardiography technique page for acquisition detail).
• Rate of pressure rise (dP/dt) — a load-independent estimate of LV contractility, derived from the continuous-wave Doppler signal of a mitral regurgitant jet:

dP/dt (mmHg/s) = 32 mmHg ÷ time (s) from 1 m/s to 3 m/s on the MR CW envelope

(32 mmHg is the pressure difference implied by the simplified Bernoulli equation between those two velocities.) Normal values are greater than 1200 mmHg/s; values below roughly 1000 mmHg/s are abnormal, with the range in between generally regarded as borderline. dP/dt is not a measure of MR severity itself — it’s a measure of contractility that happens to be derived from the MR jet’s rate of rise, a distinction worth keeping straight since the two are easy to conflate.

3D Echocardiography

3D echo measures LV volumes and EF without relying on the geometric assumptions that 2D methods make, and avoids the single-plane foreshortening risk that affects 2D measurements. It’s particularly valuable when LV geometry is distorted — a ventricular aneurysm or marked hypertrophy, for example — where 2D geometric assumptions break down most. See the Ejection Fraction tutorial for more on how 3D compares with 2D methods in practice.

Tissue Doppler Imaging (TDI)

The peak systolic annular velocity (S′), measured by tissue Doppler at the mitral annulus, is a simple, reproducible marker of longitudinal systolic function — a reduced S′ suggests systolic dysfunction. Reported normal cutoffs vary somewhat by measurement site (septal vs. lateral annulus) and source; treat any single specific cutoff as approximate rather than a sharp diagnostic line, and interpret S′ alongside the other parameters on this page rather than in isolation.

Strain Imaging (Speckle-Tracking Echocardiography)

Global longitudinal strain (GLS) measures the percentage shortening of the LV myocardium along its long axis between end-diastole and end-systole, averaged across the three standard apical views. In a healthy heart, peak GLS is typically around −20% (a more negative number indicates more shortening, i.e., better function — the sign convention can be counterintuitive at first). GLS normally declines somewhat with age and tends to run slightly more negative in women than men.

GLS’s real value is sensitivity: it can detect subclinical systolic dysfunction while EF is still in the normal range, which is exactly why it has become the standard tool for monitoring patients on cardiotoxic chemotherapy regimens — a meaningful fall in GLS can prompt closer surveillance or cardio-oncology referral well before EF itself would decline. Regional strain (segment-by-segment, rather than averaged globally) can similarly refine the wall-motion-scoring approach above with a quantitative, less subjective measurement.

Clinical Applications

• Heart failure — HFrEF is generally defined by EF < 40%, often with global hypokinesis; HFpEF by EF > 50% with diastolic dysfunction as the primary abnormality — see the Left Ventricular Diastolic Function tutorial for how that’s actually assessed. GLS is increasingly used in HFpEF evaluation specifically to detect subtle systolic impairment that a preserved EF alone would miss.
• Ischemic heart disease — regional wall motion abnormalities corresponding to a coronary territory support an ischemic etiology, and serial wall motion assessment is used to monitor for functional recovery after revascularization.
• Cardiomyopathies — dilated cardiomyopathy typically shows globally reduced EF with LV dilation; hypertrophic cardiomyopathy typically shows normal or even hyperdynamic EF alongside asymmetric septal hypertrophy — a reminder that a normal or high EF doesn’t rule out significant structural heart disease. See Introduction to Diseases of the Myocardium for how these phenotypes are classified and how echo drives the diagnostic pathway across all of them.
• Valvular heart disease — assessing the impact of regurgitant or stenotic lesions on LV systolic function, and identifying secondary LV dysfunction from chronic volume or pressure overload, is central to timing intervention in conditions covered elsewhere on this site (see the Aortic Regurgitation, Aortic Stenosis, and Mitral Regurgitation tutorials).
• Chemotherapy-related cardiotoxicity — serial GLS monitoring to detect subclinical dysfunction before a measurable drop in EF, as noted above.